Improving Clinical Trial Recruitment and Outcome Measures in Bullous Pemphigoid
Status: Completed
Location: See location...
Study Type: Observational
SUMMARY
The purpose of the study is to improve the quality of future clinical trials in bullous pemphigoid (BP), the investigators will monitor repeated measurement data from patients with BP on standard-of-care treatments at four week intervals for four months.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Males or females \> age 18
• Clinical and histological confirmation of bullous pemphigoid including at least subepidermal separation on H\&E or a positive direct immunofluorescence along with indirect immunofluorescence which demonstrates staining to the roof on salt split skin or ELISA positivity for BP180 and/or BP230 autoantibodies
• Baseline BPDAI-TAS \>5
Locations
United States
Georgia
Emory Dermatology Clinic
Atlanta
Time Frame
Start Date: 2021-03-15
Completion Date: 2023-10-06
Participants
Target number of participants: 21
Treatments
Adult bullous pemphigoid patients
Patients with diagnosis of bullous pemphigoid will participate in monitoring with face to face assessment and remote telehealth visits with store and forward images captured.
Related Therapeutic Areas
Sponsors
Leads: Emory University
Collaborators: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)